
Cytoprotective Peptides
TB-500
5mgC₂₁₂H₃₅₀N₅₆O₇₈S
Key Research Findings
- Goldstein et al. — characterisation of the Tβ4 sequence and actin-binding domain.
- Published cell-culture assays on keratinocyte and endothelial cell migration.
- Storage stability characterised in lyophilised form at −20 °C.
Overview
TB-500 is a synthetic analogue of the thymosin β4 (Tβ4) fragment. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro and animal-model studies as a G-actin-sequestering peptide active on actin polymerisation and cell-migration assays. Not intended for human or veterinary use.
Research Effects
Actin Polymerisation
Extensive ResearchReported in cell-culture assays as a G-actin sequestering peptide affecting F-actin assembly.
Cell-Migration Assays
Moderate ResearchPublished in-vitro studies report effects on keratinocyte and endothelial cell migration.
Cytokine-Expression Studies
Moderate ResearchAnimal-model studies report changes in TNF-α and related cytokine expression under controlled conditions.
Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.
Quick Facts
Research Status Key
Featured in Bundles
TB-500 is included in the following Zenterex research peptide bundles.
Related Peptides
Cytoprotective Peptides
BPC-157
BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Copper & Collagen Peptides
GHK-Cu
GHK-Cu is a synthetic copper-tripeptide complex (Glycyl-L-Histidyl-L-Lysine bound to Cu²⁺). Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
Cytoprotective Peptides
KPV
KPV is a synthetic tripeptide fragment of the α-MSH C-terminal sequence. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
